Tag: celltrion

celltrion

Latest News

Samsung, SK hynix and Celltrion to invest a combined 392 trillion won in Chungcheong region

The massive commitment, announced Thursday, centers on advanced industries including memory, display, substrates, batteries and biotech.

2026.7.2

Celltrion workers establish company's first labor union, demand compensation transparency

Workers at Celltrion, a Korean biopharmaceutical firm, launched a labor union for the first time in the company's history, demanding transparency in compensation, the union said Monday.

2026.6.1

Most popular

Celltrion Q1 net income up over 3-fold on high-margin products

Biopharmaceutical company Celltrion's net income jumped over three-fold from a year earlier, driven by robust performances of its high-margin products.

2026.5.6

Celltrion's Truxima becomes first Korea-developed biosimilar to lead U.S. market

Korean biopharmaceutical company Celltrion's biosimilar, which is used to treat blood cancers, claimed the largest share of prescriptions in the United States in February.

2026.4.7

Celltrion to cancel 1.7 trillion won in treasury shares to boost shareholder value

Celltrion, a major Korean biopharmaceutical company, said Wednesday it will cancel 1.7 trillion won ($1.1 billion) worth of treasury shares this month as part of efforts to enhance shareholder value.

2026.4.1

Seo Jung-jin, chairman of Celltrion, speaks at the general shareholders meeting at Songdo Conventia in Incheon on March 24. [YONHAP]

Celltrion chairman says firm safe from global instability at shareholder meeting

Seo Jung-jin, chairman of Celltrion Group, returned as chair of the biopharmaceutical's general shareholder meeting for the first time in 11 years on Tuesday, outlining plans to respond to global uncertainties and expand investment.

2026.3.24

Worker dies after fall at Celltrion facility in Incheon

A worker in his 20s fell to his death while carrying out maintenance work at a Celltrion facility in Incheon on Sunday, Incheon authorities said.

2026.3.23

A Celltrion plant in Songdo, Incheon [CELLTRION]

Celltrion secures 294.9 billion won drug deal from global firm

Celltrion has secured a 294.9 billion won contract to supply drugs to a global firm through 2029, potentially rising to 375.4 billion won, amid expanding its CMO business.

2026.3.17

Celltrion CEO Seo Jin-seok delivers a keynote speech on the company's future road map at the 44th J.P. Morgan Health Care Conference held in San Francisco on Jan.13. [CELLTRION]

Celltrion to internalize U.S. production with $18B investment in New Jersey facility

Celltrion plans to invest $18 billion over the next decade in its recently acquired U.S. manufacturing facility in Branchburg, New Jersey, expanding production capacity to 132,000 liters (384,871 gallons) to support production.

2026.1.15

A view of Grand Ballroom main stage at the 44th J.P. Morgan Healthcare Conference, which takes place at the Westin St. Francis hotel in San Francisco, California. The event runs until Jan. 15. [J.P. MORGAN HEALTHCARE CONFERENCE]

Korean biotech firms aim to expand U.S. presence at J.P. Morgan Healthcare Conference

At the 44th J.P. Morgan Healthcare Conference, Korean biotech firms are making efforts to enhance their presence in the U.S. market.

2026.1.13